RXRX · US market

RECURSION PHARMACEUTICALS INC CL A

Compare this company’s P/E and P/S using trailing results and the latest quarter. Ratios are calculated here from market capitalisation, signed ordinary or common-shareholder earnings and revenue.

Market cap US$2.18bnFinancials dated 30 June 2026Price dated 1 October 2026

Core valuation

Trailing P/E-4.20×

Latest-quarter run-rate P/E-4.16×

Trailing P/S39.72×

Latest-quarter run-rate P/S71.02×

Calculation inputs

Trailing earnings: -US$518.88m
Latest-quarter run-rate earnings: -US$524.02m
Latest fiscal-year earnings: -US$644.76m
Trailing revenue: US$54.86m
Latest-quarter run-rate revenue: US$30.68m
Latest fiscal-year revenue: US$74.68m

Featured ETF and mutual-fund exposure

These public funds report this company in their latest disclosed holdings.

ARKG · ARK Genomic Revolution ETF3.51% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 163 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
ARKG.L · ARK Genomic Revolution UCITS ETF2.78% weight · Holdings dated 3 August 2026
HEAL · Global X HealthTech ETF1.76% weight · Holdings dated 31 May 2026
ROBT · First Trust Nasdaq Artificial Intelligence and Robotics ETF1.46% weight · Holdings dated 30 June 2026
ARKK · ARK Innovation ETF1.16% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 163 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
ARKK.L · ARK Innovation UCITS ETF1.12% weight · Holdings dated 3 August 2026
ARKI.L · ARK Artificial Intelligence & Robotics UCITS ETF0.97% weight · Holdings dated 3 August 2026
XBI · State Street SPDR S&P Biotech ETF0.70% weight · Holdings dated 21 August 2026
VSTCX · Vanguard Strategic Small-Cap Equity Fund0.17% weight · Holdings dated 30 June 2026
PSGIX · BlackRock Advantage Small Cap Growth Fund Institutional Shares0.12% weight · Holdings dated 30 June 2026

Sources and limitations

Financial inputs are attributed to SEC EDGAR. Market cap is calculated locally where auditable price and share inputs are available. Missing data stays missing; losses are retained as signed values and produce a numeric signed P/E.

Open financial source

Financials as of 30 June 2026. Informational research, not investment advice.